Antioxidant Properties of an Endogenous Thiol: Alpha-lipoic Acid, Useful in the Prevention of Cardiovascular Diseases

被引:176
作者
Ghibu, Steliana [2 ]
Richard, Carole [1 ,3 ]
Vergely, Catherine [1 ]
Zeller, Marianne [1 ,3 ]
Cottin, Yves [1 ,3 ]
Rochette, Luc [1 ]
机构
[1] IFR Sante STIC, Lab Physiopathol & Pharmacol Cardiovasc Expt, Fac Med & Pharm, F-21000 Dijon, France
[2] Univ Cluj Napoca, Cluj Napoca, Romania
[3] CHU Bocage, Cardiol Unit, Dijon, France
关键词
lipoic acid; antioxidant; diabetes; metabolism; MITOCHONDRIAL PERMEABILITY TRANSITION; ACTIVATED PROTEIN-KINASE; PLACEBO-CONTROLLED TRIAL; LOW-DENSITY-LIPOPROTEIN; ISOLATED RAT-HEART; OXIDATIVE STRESS; SKELETAL-MUSCLE; GLUCOSE-UPTAKE; RESONANCE SPECTROSCOPY; DIHYDROLIPOIC ACID;
D O I
10.1097/FJC.0b013e3181be7554
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
In the past few years, a growing interest has been given to the possible antioxidant functions of a natural acid, synthesized in human tissues: alpha-lipoic acid (ALA). Both the oxidized (disulfide) and reduced (dithiol: dihydrolipoic acid, DHLA) forms of ALA show antioxidant properties. ALA administered in the diet accumulates ill tissues, and a substantial part is converted to DHLA via a lipoamide dehydrogenase. Commercial ALA is usually a racemic Mixture of the R and S forms. Chemical studies have indicated that ALA scavenges hydroxyl radicals, hypochlorous acid, and singlet oxygen. ALA exerts antioxidant effects ill biological systems not only through direct ROS quenching but also via transition metal chelation. ALA has been shown to possess a number of beneficial effects both in the prevention and treatment of diabetes in experimental conditions. ALA presents beneficial effects in the management of symptomatic diabetic neuropathy and has been used in this context in Germany for more than 30 years. In cardiovascular disease, dietary supplementation with ALA has been successfully employed in a variety of in vivo models: ischemia-reperfusion, heart failure, and hypertension. More mechanistic and human in vivo studies are needed to determine whether optimizing the dietary intake of ALA can help to decrease cardiovascular diseases. A more complete understanding of cellular biochemical events that influence oxidative damage is required to guide future therapeutic advances.
引用
收藏
页码:391 / 398
页数:8
相关论文
共 73 条
[1]
Assay of protein-bound lipoic acid in tissues by a new enzymatic method [J].
Akiba, S ;
Matsugo, S ;
Packer, L ;
Konishi, T .
ANALYTICAL BIOCHEMISTRY, 1998, 258 (02) :299-304
[2]
Alpha-lipoic acid ameliorates myocardial toxicity induced by doxorubicin [J].
Al-Majed, AA ;
Gado, AM ;
Al-Shabanah, OA ;
Mansour, MA .
PHARMACOLOGICAL RESEARCH, 2002, 46 (06) :499-503
[3]
Effect of DL-α-lipoic acid on neural antioxidants in aged rats [J].
Arivazhagan, P ;
Panneerselvam, C .
PHARMACOLOGICAL RESEARCH, 2000, 42 (03) :219-222
[4]
Effects of α-lipoic acid on ischemia-reperfusion-induced renal dysfunction in rats [J].
Bae, Eun Hui ;
Lee, Kyun Sang ;
Lee, JongUn ;
Ma, Seong Kwon ;
Kim, Nam Ho ;
Choi, Ki Chul ;
Frokiaer, Jorgen ;
Nielsen, Soren ;
Kim, Sun Young ;
Kim, Sung Zoo ;
Kim, Suhn Hee ;
Kim, Soo Wan .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2008, 294 (01) :F272-F280
[5]
Rate of generation of oxidative stress-related damage and animal longevity [J].
Barja, G .
FREE RADICAL BIOLOGY AND MEDICINE, 2002, 33 (09) :1167-1172
[6]
Mechanisms of antioxidant and pro-oxidant effects of α-lipoic acid in the diabetic and nondiabetic kidney [J].
Bhatti, F ;
Mankhey, RW ;
Asico, L ;
Quinn, MT ;
Welch, WJ ;
Maric, C .
KIDNEY INTERNATIONAL, 2005, 67 (04) :1371-1380
[7]
MOLECULAR ASPECTS OF THE REMOVAL OF FERRITIN-BOUND IRON BY DL-DIHYDROLIPOATE [J].
BONOMI, F ;
CERIOLI, A ;
PAGANI, S .
BIOCHIMICA ET BIOPHYSICA ACTA, 1989, 994 (02) :180-186
[8]
S-glutathiolation of p21ras by peroxynitrite mediates endothelial insulin resistance caused by oxidized low-density lipoprotein [J].
Clavreul, Nicolas ;
Bachschmid, Markus M. ;
Hou, Xiuyun ;
Shi, Chaomei ;
Idrizovic, Azra ;
Ido, Yasuo ;
Pimentel, David ;
Cohen, Richard A. .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (11) :2454-2461
[9]
Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5
[10]
Mitochondrial aldehyde dehydrogenase (ALDH-2)-Maker of and marker for nitrate tolerance in response to nitroglycerin treatment [J].
Daiber, A. ;
Wenzel, P. ;
Oelze, M. ;
Schuhmacher, S. ;
Jansen, T. ;
Muenzel, T. .
CHEMICO-BIOLOGICAL INTERACTIONS, 2009, 178 (1-3) :40-47